Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 21, 2021; 27(23): 3327-3341
Published online Jun 21, 2021. doi: 10.3748/wjg.v27.i23.3327
Published online Jun 21, 2021. doi: 10.3748/wjg.v27.i23.3327
Table 1 Comparative analysis of hepatic tuftelin 1 immunohistochemical staining and expressing intensity between hepatocellular carcinoma and their para-cancerous tissues
| Group | n | TUFT1 | χ2 value | P value | TUFT1 score | Z value | P value | ||||
| Neg. | Pos. | 0 | 1 | 2 | 3 | ||||||
| HCC | 132 | 17 | 115 | 18.563 | < 0.001 | 17 | 49 | 55 | 11 | 4.911 | < 0.001 |
| Non-HCC | 132 | 47 | 85 | 47 | 54 | 23 | 8 | ||||
- Citation: Wu MN, Zheng WJ, Ye WX, Wang L, Chen Y, Yang J, Yao DF, Yao M. Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth. World J Gastroenterol 2021; 27(23): 3327-3341
- URL: https://www.wjgnet.com/1007-9327/full/v27/i23/3327.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i23.3327